Active Ingredient(s): Isoniazid, INH + Rifampin
FDA Approved: * July 11, 1975
Pharm Company: * SANOFI AVENTIS US
Category: Tuberculosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rifamate Overview

Isoniazid, also known as isonicotinic acid hydrazide (INH), is an antibiotic used for the treatment of tuberculosis.[2] For active tuberculosis it is often used together with rifampicin, pyrazinamide, and either streptomycin or ethambutol.[3] For latent tuberculosis it is often used by itself.[2] It may also be used for atypical types of mycobacteria, such as M. avium, M. kansasii, and M. xenopi.[2] It is usually taken by mouth b...

Read more Rifamate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Isoniazid

Recent Rifamate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Isoniazid, INH + Rifampin
  • Capsule: 150mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rifamate: (1 result)

Sorted by National Drug Code
  • 0068-0509 Rifamate 150 mg-300 mg Oral Capsule by Sanofi-aventis U.S. LLC

Drugs with one or more similar ingredients: (10 results)